Detection of Mammaglobin mRNA in the Plasma of Breast Cancer Patients
Shira Gal, Carrie Fidler, Y. M. Dennis Lo, Kenny Chin, JOHN MOORE, Adrian L. Harris, James S. Wainscoat
Abstract
Shira Gal, Carrie Fidler, Y. M. Dennis Lo, Kenny Chin, JOHN MOORE, Adrian L. Harris, James S. Wainscoat
Abstract
It has been suggested that mammaglobin may be a useful marker for breast cancer clinical research. Studies investigating the detection of mRNA by RT-PCR from circulating carcinoma cells in the peripheral blood of breast cancer patients have shown that mammaglobin is a highly specific marker and correlates with several prognostic factors, such as lymph node involvement. We aimed to detect cell-free mammaglobin mRNA in the plasma of breast cancer patients and to investigate whether it can be used as a marker for diagnosis of breast cancer.
OpenAlex reports 35 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
It has been suggested that mammaglobin may be a useful marker for breast cancer clinical research. Studies investigating the detection of mRNA by RT-PCR from circulating carcinoma cells in the peripheral blood of breast cancer patients have shown that mammaglobin is a highly specific marker and correlates with several prognostic factors, such as lymph node involvement. We aimed to detect cell-free mammaglobin mRNA in the plasma of breast cancer patients and to investigate whether it can be used as a marker for diagnosis of breast cancer.
Key concepts: Mammaglobin, Breast cancer, Medicine, Lymph node, Cancer, Oncology, Internal medicine, Breast carcinoma